AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 57 filers reported holding AKCEA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $83,000 | -81.3% | 4,600 | -68.7% | 0.00% | -100.0% |
| Q4 2018 | $443,000 | -13.8% | 14,700 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $514,000 | +47.7% | 14,700 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $348,000 | +216.4% | 14,700 | +241.9% | 0.00% | – |
| Q1 2018 | $110,000 | +48.6% | 4,300 | 0.0% | 0.00% | – |
| Q4 2017 | $74,000 | -37.3% | 4,300 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $118,000 | – | 4,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |